Researchers have built a miniature human bladder with urine flowing through it, and the device has offered a concrete explanation for something millions of people experience as a personal failure: a urinary tract infection that comes back weeks after antibiotics supposedly cleared it.
The answer, in this laboratory model, is that some of the bacteria were never reachable in the first place.
A team led by University College London with the University of Oxford and the University of Leicester engineered a three-dimensional micro-bladder that reproduces the flow conditions of the human urinary tract. When they introduced the bacteria responsible for most urinary tract infections, the organisms stuck to the bladder surface more effectively and invaded the lining, establishing what the researchers call reservoirs inside bladder cells.
The Reason a Standard Lab Test Can Say a Drug Works When It Does Not
Hospitals routinely test bacteria from a patient’s urine to determine which antibiotics stop them growing. Those tests are usually performed in still, nutrient-rich liquid in a dish.
A real bladder does not resemble that at all. Urine moves constantly, filling and emptying on a cycle, and bacteria are in continuous contact with living tissue. The gap between those two environments turns out to matter enormously.
The team tested nitrofurantoin, one of the most commonly prescribed antibiotics for urinary tract infections. It performed well in the standard test. In the micro-bladder, it struggled to fully clear the infection. The difference was not the drug or the bacterial strain. It was the environment the test was run in, which is a finding about laboratory methods as much as about treatment.
Senior author Professor Jennifer Rohn of the UCL Division of Medicine said building the device allowed the team to see «why antibiotics that look powerful in standard lab tests often fall short.»
That finding does not mean nitrofurantoin does not work. It works for a great many people. But it offers a mechanism for why a subset of patients keep relapsing despite a drug the laboratory said should have succeeded.
Bacteria That Hide Inside the Bladder Wall
The reservoir concept is central here. Rather than living entirely in the urine where a drug can reach them, some uropathogenic Escherichia coli invade the bladder lining and persist inside cells. The same laboratory reported earlier evidence of bacteria sheltering in the bladder wall. Rohn said recurrent infections frustrate patients because the bacteria can survive antibiotics by retreating into protected reservoirs inside the bladder wall.
Urinary tract infections are among the most common infections in the world, with roughly 400 million cases occurring each year by the researchers’ own count, and the Centers for Disease Control and Prevention notes they are usually treated with antibiotics. For people who cycle through repeated courses, the reservoir explanation reframes the experience. It is not a matter of having taken the pills incorrectly.
A Combination That Worked Better Than Either Treatment Alone
The team also tested a cocktail of bacteriophages, viruses that infect and destroy bacteria without harming human cells.
On its own, the phage cocktail also struggled to clear bacteria in the flowing environment. Combined with the antibiotic, results improved, suggesting a two-pronged approach could outperform either treatment used alone.
The more striking result concerned the reservoirs. Unlike the antibiotic, phage treatment reduced the number of protected bacterial populations inside the bladder wall. Because those reservoirs are thought to seed future infections, reducing them could matter for prevention rather than just for treating the current episode.
Lead author Dr. Ramon Garcia Maset said phage therapy reached «these hidden reservoirs of bacteria, rooting out the cause of the infection.» He added that urine flow substantially changed how bacteria behaved and responded to treatment, which suggests conventional laboratory tests may be missing important aspects of infection.
The researchers also observed signs that phages boosted the bladder tissue’s own early immune response, including increased signaling from cytokines and chemokines.
Professor Martha Clokie, director of the Becky Mayer Centre for Phage Research at the University of Leicester, said the work shows why testing phages under conditions that genuinely reflect the human body is important, and that combining a realistic model with both treatments allows researchers to understand how to use phages alongside existing medicines.
Nothing Here Is Available at a Pharmacy Yet
This is laboratory work. No patients were treated, and the findings involve cells and bacteria in a device rather than people.
Phage therapy is not a routine treatment for urinary tract infections anywhere. More research is needed to confirm how well it works, how best to deliver it, and which patients would benefit. Anyone encountering phage therapy advertised online or through a clinic promising treatment for recurrent infections should approach that with considerable caution, because the evidence base does not currently support it as an established option.
For people living with recurrent infections now, the practical guidance is unchanged. Symptoms including burning during urination, urgency, frequent urination and cloudy or strong-smelling urine warrant medical evaluation rather than self-treatment with leftover antibiotics. Fever, flank or back pain, nausea or confusion can signal that an infection has reached the kidneys and needs prompt attention. Anyone with frequent recurrences can ask a clinician about referral to a urologist and about preventive strategies that already have evidence behind them.
The study was published in Nature Communications and conducted as part of the Beyond Antibiotics Programme Grant, funded by the Engineering and Physical Sciences Research Council. The group studying bladder infection and cancer has made the device design and image-analysis tools freely available so other laboratories can adopt them, which is the development most likely to produce further findings in the near term.
Key Questions Answered
What did researchers build? A three-dimensional laboratory model of a human bladder that includes flowing urine, designed to reproduce conditions in the real urinary tract more closely than a standard dish test.
Why do urinary tract infections keep coming back? In this model, bacteria invaded the bladder lining and established protected reservoirs inside cells, where the antibiotic tested could not fully reach them.
Did a common antibiotic fail? Nitrofurantoin performed well in a standard laboratory test but struggled to clear infection in the flowing bladder model. This does not mean it does not work for patients, and no one should stop a prescribed antibiotic.
What is phage therapy? The use of viruses that infect and kill bacteria without harming human cells. In this study, phages reduced hidden bacterial reservoirs that the antibiotic did not.
Is phage therapy available for urinary tract infections? No. It is not a routine treatment anywhere, and more research is needed on effectiveness, delivery, and which patients might benefit.
What symptoms need medical attention? Burning during urination, urgency, frequent urination, and cloudy urine warrant evaluation. Fever, back or flank pain, nausea or confusion may indicate a kidney infection requiring prompt care.
What happens next? The team released its device design and analysis tools for other laboratories to use. Human studies would be required before phage therapy could be considered for patients.
